# BioActor

> BioActor is a VC fund in Maastricht backing Wellness and Health Care. See 1 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Maastricht, The Netherlands
- Total investments: 1
- Last investment: Jan 2023
- Lead investor: 0%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/bioactor-bv
- Website: http://www.bioactor.com

BioActor is a VC fund in Maastricht focused on Wellness and Health Care. BioActor develops proprietary health ingredients for use in functional foods, medical nutrition and dietary supplements. All these ingredients address chronic health concerns, such as diabetes,osteoporosis, cardiovascular disease, that would benefit from preventative measures through the diet. BioActor's product development strategy relies onthree simple tenets: a new health ingredient must be based on a patentable scientific discovery; it must be food grade from a natural and renewable source; and its health effect must be clinically proven. BioActor's first product, BONOLIVE, a first in class bone health ingredient that is clinically proven to stimulate bone producing cells, is a great example of this strategy and will be launched in the USA this year. BioActor successfully implemented its product development strategy by establishing alliances with top nutrition research institutes (e.g. INRA, CSIC, Maastricht University, UCL, Ghent University) and by establishing production partnerships with industrial players to shorten the path to market.

## Contacts

5 contacts available for BioActor. Shizune tracks 4 team members at BioActor. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/bioactor?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Wellness | 1 | 100% |
| Health Care | 1 | 100% |
| Biotechnology | 1 | 100% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Hans van der Saag | Chief Executive Officer | 1 | https://shizune.co/investors/profile/hans-van-der-saag |
| Ariel Changyun Zhang | Business Development Manager for Asia Region | 0 | https://shizune.co/investors/profile/ariel-changyun-zhang |
| Kevin Wilson | Commercial Manager of Health and Nutrition for Europe, Middle East, and Asia and North America | 0 | https://shizune.co/investors/profile/kevin-wilson-40ca |
| Yala Stevens | Head of Clinical Research | 0 | https://shizune.co/investors/profile/yala-stevens |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| NapiFeryn BioTech | NapiFeryn BioTech extracts protein from rapeseed oil production waste streams for functional, nutritional, and cost-effective protein isolates and concentrates. These ingredients are a sustainable alternative to animal-derived proteins, are nutritional, and can be used in a wide variety of applications | $2.7M | Venture - Series Unknown | Jan 30, 2023 |  |

1 of 1 investments shown.

## Co-investors
- [ICOS Capital Management](https://shizune.co/investors/profile/icoscapital) — VC Fund, 1 deal together
- [Innovopro](https://shizune.co/investors/profile/innovopro) — VC Fund, 1 deal together
- [NutriLeads](https://shizune.co/investors/profile/nutrileads) — VC Fund, 1 deal together
- [WholeFiber](https://shizune.co/investors/profile/wholefiber) — VC Fund, 1 deal together

## Similar investors

### Similar industry
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [ARCH Venture Partners](https://shizune.co/investors/profile/arch-venture-partners) — VC Fund
- [OrbiMed](https://shizune.co/investors/profile/orbimed-advisors) — VC Fund

### Similar stage
- [Bossa Invest](https://shizune.co/investors/profile/bossanova-investimentos) — VC Fund
- [Almi Invest](https://shizune.co/investors/profile/almi-invest) — VC Fund
- [Korea Credit Guarantee Fund](https://shizune.co/investors/profile/korea-credit-guarantee-fund) — VC Fund

### Similar country
- [SpeedUp Venture Capital Group](https://shizune.co/investors/profile/speedup-venture-capital-group) — VC Fund
- [SMOK Ventures](https://shizune.co/investors/profile/smok-ventures) — VC Fund
- [LT Capital](https://shizune.co/investors/profile/lt-capital-5861) — VC Fund

## Featured in investor lists
- [Wellness Investors in Poland](https://shizune.co/investors/wellness-investors-poland)
- [Biotech Investors in Poland](https://shizune.co/investors/biotech-investors-poland)
- [Biotech VC Funds in Poland](https://shizune.co/investors/biotech-vc-funds-poland)
- [Wellness VC Funds in Poland](https://shizune.co/investors/wellness-vc-funds-poland)
- [Biotechnology Investors in Poland](https://shizune.co/investors/biotechnology-investors-poland)
- [Biotechnology VC Funds in Poland](https://shizune.co/investors/biotechnology-vc-funds-poland)

## FAQ

### What does BioActor invest in?

BioActor invests primarily in Wellness, Health Care and Biotechnology startups, most often at Venture - Series Unknown stage. Most of the 1 investments tracked by Shizune back companies in Poland. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact BioActor?

Public channels for BioActor include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at BioActor?

The team at BioActor includes Hans van der Saag (Chief Executive Officer), Ariel Changyun Zhang (Business Development Manager for Asia Region) and Kevin Wilson (Commercial Manager of Health and Nutrition for Europe, Middle East, and Asia and North America). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co